Effect of vaccination against Mycoplasma hyopneumoniae in a pig herd from birth to slaughter

被引:3
|
作者
Siugzdaite, J [1 ]
Garlaite, K [1 ]
机构
[1] Lithuanian Vet Acad, LT-3022 Kaunas, Lithuania
关键词
enzootic pneumonia; antibodies; immune; response;
D O I
10.2754/avb200271040549
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Mycoplasma hyopneumoniae remains an important pathogen in swine industry. The aim of the present work was to assess M. hyopneumoniae vaccine from viewpoint of antibodies formation, health, daily weight gain, quality of meat and lung lesions. The investigation was Carried Out Oil forty four cross-bred 7-day-old piglets free from M. hyopneumoniae infection. Twenty two piglets were vaccinated intramuscularly. The other group of twenty two piglets was used as a control (unvaccinated). The results showed that in both groups the antibodies against Mycoplasma hyopneumoniae were not formed before vaccination, Antibodies against enzootic pneumonia in the vaccinated group were formed after fourteen days from the second vaccination and remained present until day 77. It was observed that in unvaccinated group antibodies against M. hyopneumoniae had not been formed. Pigs with artificially acquired active immunity from vaccination achieved higher daily weight gain, growth rate, fattening and finishing weight, improved quality of meat and decreased pneumonia lesions than the pigs in the control group.
引用
收藏
页码:549 / 553
页数:5
相关论文
共 50 条
  • [1] Effect of sow vaccination against Mycoplasma hyopneumoniae on sow and piglet colonization and seroconversion, and pig lung lesions at slaughter
    Sibila, M.
    Bernal, R.
    Torrents, D.
    Riera, P.
    Llopart, D.
    Calsamiglia, M.
    Segales, J.
    VETERINARY MICROBIOLOGY, 2008, 127 (1-2) : 165 - 170
  • [2] Effect of vaccination against Mycoplasma hyopneumoniae on divergent pig genetic groups
    Sousa, Katiene Regia Silva
    Dantas, Waleska de Melo Ferreira
    de Oliveira, Leandro Licursi
    Cardoso, Silvia Almeida
    Araujo, Renan dos Santos
    Guimaraes, Simone Eliza Facioni
    RESEARCH IN VETERINARY SCIENCE, 2024, 180
  • [3] Clinical efficacy of two vaccination strategies against Mycoplasma hyopneumoniae in a pig herd suffering from respiratory disease
    Vojislav Cvjetković
    Sabine Sipos
    Imre Szabó
    Wolfgang Sipos
    Porcine Health Management, 4
  • [4] Clinical efficacy of two vaccination strategies against Mycoplasma hyopneumoniae in a pig herd suffering from respiratory disease
    Cvjetkovic, Vojislav
    Sipos, Sabine
    Szabo, Imre
    Sipos, Wolfgang
    PORCINE HEALTH MANAGEMENT, 2018, 4
  • [5] The effect of vaccination against Mycoplasma hyopneumoniae in pig herds with a continuous production system
    Maes, D
    Deluyker, H
    Verdonck, M
    Castryck, F
    Miry, C
    Lein, A
    Vrijens, B
    de Kruif, A
    JOURNAL OF VETERINARY MEDICINE SERIES B-INFECTIOUS DISEASES AND VETERINARY PUBLIC HEALTH, 1998, 45 (08): : 495 - 505
  • [6] Comparison of the effects of vaccination and pulse medication in a pig herd infected with Mycoplasma hyopneumoniae.
    LeGrand, A
    Kobisch, M
    VETERINARY RESEARCH, 1996, 27 (03) : 241 - 253
  • [7] Intradermal vaccination against Mycoplasma hyopneumoniae
    Palzer, A
    TIERAERZTLICHE PRAXIS AUSGABE GROSSTIERE NUTZTIERE, 2006, 34 (03): : 202 - 202
  • [8] Vaccination of sows against Mycoplasma hyopneumoniae with Hyoresp®
    Beilage, EG
    Schreiber, A
    DEUTSCHE TIERARZTLICHE WOCHENSCHRIFT, 2005, 112 (07): : 256 - 261
  • [9] Association of lung score findings from slaughter pigs with their vaccination status against Mycoplasma hyopneumoniae and PCV2
    Sipos, Wolfgang
    Dobrokes, Branimir
    Meppiel, Laurianne
    Sailer, Judith
    Friedmann, Ursula
    Cyjetkovic, Vojislav
    BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT, 2020, 133 : 1 - 5
  • [10] Effect of vaccination against Mycoplasma hyopneumoniae in pig herds with an all-in/all-out production system
    Maes, D
    Deluyker, H
    Verdonck, M
    Castryck, F
    Miry, C
    Vrijens, B
    Verbeke, W
    Viaene, J
    de Kruif, A
    VACCINE, 1999, 17 (9-10) : 1024 - 1034